What happened
SK biopharmaceuticals disclosed a supply contract with SK Life Science,Inc., worth US$33.5M, about 8.8% of its recent annual revenue, running through Feb 2026.
For context, this single contract equals about 8.8% of the company's most recent annual revenue.
| Counterparty | SK Life Science,Inc. |
|---|---|
| Contract value | US$33.5M |
| vs. recent revenue | 8.8% |
| Through | Feb 2026 (from Feb 2026) |
| Filed | 2026-02-24, Supply contract signed |
| Source | DART rcept 20260224800167 → open original filing |
Source: DART. Information only, not investment advice.